Streaming platform pioneer Roku finds itself at a strategic crossroads, championing an artificial intelligence-driven advertising offensive while a prominent investor scales back their stake. The ...
MYR delivered exceptional financial results for the second quarter of 2025, providing a fundamental catalyst for the recent rally. The company posted a record net income of $26.5 million, which ...
Although now mostly known as a company who cornered the market on graphing calculators while only updating them once a decade ...
A single-family home under construction along Cedar Grove Way in west Lawrence is shown on July 7, 2025. The City of Lawrence will add two new programs that aim to streamline the building inspection ...
Learn how to run ChatGPT 4-level AI locally for free. No API fees, no servers—just a private, powerful AI system on your ...
Those of you who'd like to check out upcoming AI tools and tricks in Windows may be interested in a new program from Microsoft. Known as Windows AI Labs, this one invites you to check out experimental ...
Pima JTED is preparing high school students for future tech careers through hands-on robotics and artificial intelligence ...
The University of Oklahoma is launching a certified registered nurse anesthetist program, the first of its kind at a public university in the state, university officials said. Oklahoma faces a ...
54 shot, 7 dead, in Chicago amid Trump's threat to deploy National Guard Tiny African country detaining five deported US migrants asked Trump team for $500 million: report Tropical Storm Gabrielle ...
A member of Congress from Ohio is calling for a pilot program that would add prior authorization for some traditional fee-for-service Medicare services to be halted until an independent review board ...
The Allen County Election Board’s decision to amend its proposal for vote centers is a reminder of how democracy should work. Officials didn’t just bend to the will of the crowd; they listened, ...
MILAN--(BUSINESS WIRE)--Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the ...